Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
about
A new strategy to fight antimicrobial resistance: the revival of old antibioticsAntimicrobial Drugs in Fighting against Antimicrobial ResistanceHow to educate prescribers in antimicrobial stewardship practicesReviving old antibioticsEndless Resistance. Endless Antibiotics?Surveillance of Gram-negative bacteria: impact of variation in current European laboratory reporting practice on apparent multidrug resistance prevalence in paediatric bloodstream isolatesFosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota.Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.Global survey of polymyxin use: A call for international guidelines.Developing new antibacterials through natural product research.New pharmacological treatments for methicillin-resistant Staphylococcus aureus infections.Product information for parenteral colistin varies substantially across Europe.Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era.Tackling antibiotic resistance in India.Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations.Using antibiotics responsibly: are we there yet?A review of the pharmacokinetics and pharmacodynamics of aztreonam.Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009.Revisiting Nitrofurantoin for Vancomycin Resistant Enterococci.In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa.Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?Perspectives and concerns regarding antimicrobial agent shortages among infectious disease specialists.Protoilludane sesquiterpenoids as scaffold structures for new antimicrobials against Mannheimia haemolytica.Establishing quality control ranges for temocillin following CLSI-M23-A3 guideline.Phenoxymethylpenicillin Versus Amoxicillin for Infections in Ambulatory Care: A Systematic Review
P2860
Q21131083-4AA75C98-C723-4AE9-9B40-6301C4DA67F1Q26752527-054D2670-069A-4896-BA15-8238C7CA0EC3Q26851384-B10EB718-FB0D-41E5-8047-956D538A4493Q26853271-F5668242-70FD-414D-8D16-627F29D8EE89Q28822179-222E084E-4200-4E2D-86AC-1DBF66BCE34FQ33575730-672526B5-E6B1-48D1-9A7E-1522CF8994D4Q35278325-7CC3C815-21E3-4F9D-AD19-41A7158540C9Q35576364-18D85398-204F-4F12-8712-05505E6AEA61Q35960788-BEDF6B65-F0D9-4A2F-9910-8032CBDC4C8AQ37709735-36FC181A-ED6B-4E58-BFFA-2409B0126230Q38088256-6061A3B0-D6AB-4E5F-92C2-4BE27D90DE36Q38179460-52F1BDDE-CCA2-43E2-A164-1FB49CF58B5EQ38196299-5387882F-FBB7-42BD-8AF9-8E293B5909E9Q38201118-0FD4F7CE-154E-456D-8F44-A503C6AC353FQ38263590-B326C686-6896-4454-9FCB-6F8C9BFCA3F2Q38599622-9B55BD1C-B429-42FD-AF61-C0CF2F5B9418Q38833383-81C84875-45DF-4467-B9EB-AE3DFEDA2703Q38873850-261F2C6E-D079-4AF0-9CC8-6CB19AECC542Q39340620-7BBD7087-FD6C-4E40-B9C3-6A4E6B26F7EDQ40111075-103AE32B-F3A2-411E-AA66-452F2D967D0BQ40698278-BC5294AC-F0B7-4487-AE6D-F8CBC033222EQ41172930-9C4EBC5D-A546-42F4-9C84-6BFECD30C229Q42242522-E91FBBEC-D996-4C86-88BB-44A9878E6623Q42279326-1F759B37-CDAC-4113-8A74-15CDADA6EAD6Q43681145-A5F07672-7189-4E07-B574-E7F3576B169AQ50637956-43AC03BF-5649-4934-B693-5DAF4359ADC9Q58764263-ADB92A6B-6594-4FC9-A7C2-0C547CFB1388
P2860
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
@en
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
@nl
type
label
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
@en
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
@nl
prefLabel
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
@en
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
@nl
P2093
P2860
P50
P921
P356
P1476
Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia.
@en
P2093
ESCMID Study Group for Antibiotic Policies
Inge C Gyssens
John Turnidge
M Lindsay Grayson
Niels Frimodt-Møller
William A Craig
P2860
P304
P356
10.1093/CID/CIR838
P407
P577
2012-01-01T00:00:00Z